{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:10:54Z","timestamp":1778659854959,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10792-017-0811-0","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T04:47:26Z","timestamp":1516682846000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Role of topical interferon alpha-2b in \u2018mitomycin-C-resistant\u2019 ocular surface squamous neoplasia: our preliminary findings"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2846-0597","authenticated-orcid":false,"given":"Manpreet","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"811_CR1","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","volume":"121","author":"AA Nanji","year":"2014","unstructured":"Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL (2014) Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmology 121:994\u20131000","journal-title":"Ophthalmology"},{"key":"811_CR2","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ophtha.2008.01.006","volume":"115","author":"A Sturges","year":"2008","unstructured":"Sturges A, Butt AL, Lai JE, Chodosh J (2008) Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 115:1297\u20131302","journal-title":"Ophthalmology"},{"key":"811_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/08820530500351694","volume":"21","author":"AM Poothullil","year":"2006","unstructured":"Poothullil AM, Colby KA (2006) Topical medical therapies for ocular surface tumors. Semin Ophthalmol 21:161\u2013169","journal-title":"Semin Ophthalmol"},{"key":"811_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0002-9394(14)70822-0","volume":"124","author":"MW Wilson","year":"1997","unstructured":"Wilson MW, Hungerford JL, George SM, Madreperla SA (1997) Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 124:303\u2013311","journal-title":"Am J Ophthalmol"},{"key":"811_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0161-6420(95)30866-4","volume":"102","author":"RP Yeatts","year":"1995","unstructured":"Yeatts RP, Ford JG, Stanton CA, Reed JW (1995) Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea. Ophthalmology 102:1338\u20131344","journal-title":"Ophthalmology"},{"key":"811_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1001\/archophthalmol.2011.385","volume":"130","author":"SU Shah","year":"2012","unstructured":"Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL (2012) Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Arch Ophthalmol 130:159\u2013164","journal-title":"Arch Ophthalmol"},{"key":"811_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000086183","volume":"14","author":"YA Luqmani","year":"2005","unstructured":"Luqmani YA (2005) Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 14:35\u201348","journal-title":"Med Princ Pract"},{"key":"811_CR8","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N, Sarkar S (2014) Drug resistance in cancer: an overview. Cancers 6:1769\u20131792","journal-title":"Cancers"},{"key":"811_CR9","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"R Gorlick","year":"1996","unstructured":"Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR (1996) Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335:1041\u20131048","journal-title":"N Engl J Med"},{"key":"811_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ICO.0000000000001153","volume":"36","author":"N Ashkenazy","year":"2017","unstructured":"Ashkenazy N, Karp CL, Wang G, Acosta CM, Galor A (2017) Immunosuppression as a possible risk factor for interferon nonresponse in ocular surface squamous neoplasia. Cornea 36:506\u2013510","journal-title":"Cornea"},{"key":"811_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0161-6420(97)30287-5","volume":"104","author":"G Tabin","year":"1997","unstructured":"Tabin G, Levin S, Snibson G, Loughnan M, Taylor H (1997) Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology 104:485\u2013492","journal-title":"Ophthalmology"},{"key":"811_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.ico.0000138834.42489.ba","volume":"24","author":"DU Stone","year":"2005","unstructured":"Stone DU, Butt AL, Chodosh J (2005) Ocular surface squamous neoplasia: a standard of care survey. Cornea 24:297\u2013300","journal-title":"Cornea"},{"key":"811_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ICO.0b013e3182523f61","volume":"32","author":"CL Shields","year":"2013","unstructured":"Shields CL, Kaliki S, Kim HJ, Al-Dahmash S, Shah SU, Lally SE, Shields JA (2013) Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification. Cornea 32:248\u2013256","journal-title":"Cornea"},{"key":"811_CR14","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.ophtha.2004.02.013","volume":"111","author":"CL Shields","year":"2004","unstructured":"Shields CL, Demirci H, Karatza E, Shields JA (2004) Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 111:1747\u20131754","journal-title":"Ophthalmology"},{"key":"811_CR15","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.ophtha.2012.02.049","volume":"119","author":"AA Kao","year":"2012","unstructured":"Kao AA, Galor A, Karp CL, Abdelaziz A, Feuer WJ, Dubovy SR (2012) Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001\u20132010. Ophthalmology 119:1773\u20131776","journal-title":"Ophthalmology"},{"key":"811_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ophtha.2011.08.028","volume":"119","author":"JZ Kieval","year":"2012","unstructured":"Kieval JZ, Karp CL, AbouShousha M, Galor A, Hoffman RA, Dubovy SR, Wang J (2012) Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology 119:481\u2013486","journal-title":"Ophthalmology"},{"key":"811_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/eye.2012.15","volume":"26","author":"Y Xu","year":"2012","unstructured":"Xu Y, Zhou Z, Xu Y, Wang M, Liu F, Qu H, Hong J (2012) The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye 26:781\u2013787","journal-title":"Eye"},{"key":"811_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/archopht.1994.01090210029007","volume":"112","author":"SL Maskin","year":"1994","unstructured":"Maskin SL (1994) Regression of limbal epithelial dysplasia with topical interferon (letter). Arch Ophthalmol 112:1145\u20131146","journal-title":"Arch Ophthalmol"},{"key":"811_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.ophtha.2004.01.034","volume":"111","author":"MD Boehm","year":"2004","unstructured":"Boehm MD, Huang AJ (2004) Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology 111:1755\u20131761","journal-title":"Ophthalmology"},{"key":"811_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.4103\/0301-4738.195013","volume":"64","author":"M Singh","year":"2016","unstructured":"Singh M, Gautam N, Gupta A, Kaur M (2016) Interferon alfa-2b in the management of recurrent conjunctival papillomatosis. Indian J Ophthalmol 64:778\u2013780","journal-title":"Indian J Ophthalmol"},{"key":"811_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/sj.eye.6700331","volume":"17","author":"G Peksayar","year":"2003","unstructured":"Peksayar G, Altan-Yaycioglu R, Onal S (2003) Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours. Eye (Lond) 17:228\u2013232","journal-title":"Eye (Lond)"},{"key":"811_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00003226-200201000-00004","volume":"21","author":"CS Siganos","year":"2002","unstructured":"Siganos CS, Kozobolis VP, Christodoulakis EV (2002) The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation. Cornea 21:12\u201316","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0811-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T14:16:19Z","timestamp":1572012979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["811"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0811-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"17 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The written informed consent was obtained from all the participants before starting topical interferon therapy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}